Sanofi (SNY) Debt Ratio (2009 - 2025)

Sanofi has disclosed Debt Ratio across 17 years of filings, most recently posting 0.15 for Q4 2025.

• Debt Ratio for Q4 2025 came in at 0.15, up 21.68% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.15 (up 21.68% YoY), and the FY2025 annual result was 0.15, up 21.68% from the prior year.
• Debt Ratio came in at 0.15 for Q4 2025 at Sanofi, down from 0.16 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.18 in Q2 2021 to a low of 0.12 in Q4 2024.
• The 5-year median for Debt Ratio is 0.15 (2022), against an average of 0.15.
• Across the five-year window, Debt Ratio plunged 98.8% in 2021 and climbed 21.68% in 2025, its largest moves.
• Sanofi's Debt Ratio stood at 0.17 in 2021, then decreased by 11.07% to 0.15 in 2022, then retreated by 13.69% to 0.13 in 2023, then declined by 7.05% to 0.12 in 2024, then climbed by 21.68% to 0.15 in 2025.
• The last three Debt Ratio figures came in at 0.15 (Q4 2025), 0.16 (Q2 2025), and 0.12 (Q4 2024), per Business Quant data.